We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Outcome of request to invalidate, hearing held on 29 April 2024.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
How to use a randomised controlled trial to evaluate your digital health product.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to use a before-and-after study to evaluate your digital health product.
Find out about your human rights and how they are protected.
Free and impartial help with money and pensions.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
If you manage an online platform that allows user generated content, these 7 steps will help you keep your business and your users safe.
Find news, information and advice from the government on starting or growing your business.
Data on the real-world efficacy of the COVID-19 vaccines.
Who is eligible for Darwin Plus project and fellowship funding, and how to apply.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
How to choose data tools and infrastructure that are flexible, scalable, sustainable and secure.
Transport analysis guidance (TAG) provides information on the role of transport modelling and appraisal.
Advice and guidance on the health needs of migrant patients from Colombia for healthcare practitioners.
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.